AMP-activated protein kinase determines apoptotic sensitivity of cancer cells to ginsenoside-Rh2

Attele, 1999, Ginseng pharmacology: multiple constituents and multiple actions, Biochem Pharmacol, 58, 1685, 10.1016/S0006-2952(99)00212-9 Xie, 2005, Ginseng and diabetes, Am J Chin Med, 33, 397, 10.1142/S0192415X05003004 Hwang, 2007, Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte, Biochem Biophys Res Commun, 364, 1002, 10.1016/j.bbrc.2007.10.125 Cho, 2006, Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats, Eur J Pharmacol, 550, 173, 10.1016/j.ejphar.2006.08.056 Shang, 2008, Ginsenoside Rb1 stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes, J Endocrinol, 198, 561, 10.1677/JOE-08-0104 Song, 2003, Cytokine modulating effect of ginseng treatment in a mouse model of Pseudomonas aeruginosa lung infection, J Cyst Fibros, 2, 112, 10.1016/S1569-1993(03)00065-1 Lee, 2004, Ginsenoside Rg1 enhances CD4(+) T-cell activities and modulates Th1/Th2 differentiation, Int Immunopharmacol, 4, 235, 10.1016/j.intimp.2003.12.007 Han, 2005, Ginsan improved Th1 immune response inhibited by gamma radiation, Arch Pharm Res, 28, 343, 10.1007/BF02977803 Jia, 2004, Rh2, a compound extracted from ginseng, hypersensitizes multidrug-resistant tumor cells to chemotherapy, Can J Physiol Pharmacol, 82, 431, 10.1139/y04-049 Choi, 2009, Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1-dependent inhibition of cyclin-dependent kinases, Pharm Res, 26, 2280, 10.1007/s11095-009-9944-9 Mochizuki, 1995, Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng, Biol Pharm Bull, 18, 1197, 10.1248/bpb.18.1197 Xu, 2007, Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer, Chin Med J (Engl), 120, 584, 10.1097/00029330-200704010-00011 Molnar, 2000, Membrane associated antitumor effects of crocine-, ginsenoside- and cannabinoid derivates, Anticancer Res, 20, 861 Fei, 2002, Apoptotic effects of ginsenoside Rh2 on human malignant melanoma A375-S2 cells, Acta Pharmacol Sin, 23, 315 Jin, 2000, Caspase 3-mediated cleavage of p21WAF1/CIP1 associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells, J Biol Chem, 275, 30256, 10.1074/jbc.M001902200 Oh, 1999, Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells, Int J Oncol, 14, 869 Kim, 2004, Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells, Arch Pharm Res, 27, 429, 10.1007/BF02980085 Hardie, 2007, AMP-activated protein kinase as a drug target, Annu Rev Pharmacol Toxicol, 47, 185, 10.1146/annurev.pharmtox.47.120505.105304 Motoshima, 2006, AMPK and cell proliferation—AMPK as a therapeutic target for atherosclerosis and cancer, J Physiol, 574, 63, 10.1113/jphysiol.2006.108324 Luo, 2005, AMPK, the metabolic syndrome and cancer, Trends Pharmacol Sci, 26, 69, 10.1016/j.tips.2004.12.011 Kim, 2008, Inhibition of AMP-activated protein kinase sensitizes cancer cells to cisplatin-induced apoptosis via hyper-induction of p53, J Biol Chem, 283, 3731, 10.1074/jbc.M704432200 Kato, 2002, Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation, Oncogene, 21, 6082, 10.1038/sj.onc.1205737 Yang, 2009, Ginsenoside Rh2 ameliorates scopolamine-induced learning deficit in mice, Biol Pharm Bull, 32, 1710, 10.1248/bpb.32.1710 Oh, 2005, Caspase-3-dependent protein kinase C delta activity is required for the progression of ginsenoside-Rh2-induced apoptosis in SK-HEP-1 cells, Cancer Lett, 230, 228, 10.1016/j.canlet.2004.12.043 Cheng, 2005, Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells, Cancer Chemother Pharmacol, 55, 531, 10.1007/s00280-004-0919-6 Kim, 2004, Ginsenoside Rh2 induces apoptosis via activation of caspase-1 and -3 and up-regulation of Bax in human neuroblastoma, Arch Pharm Res, 27, 834, 10.1007/BF02980175 Sandstrom, 2006, Role of reactive oxygen species in contraction-mediated glucose transport in mouse skeletal muscle, J Physiol, 575, 251, 10.1113/jphysiol.2006.110601 Choi, 2001, The regulation of AMP-activated protein kinase by H(2)O(2), Biochem Biophys Res Commun, 287, 92, 10.1006/bbrc.2001.5544 Ham, 2003, The c-Jun N-terminal kinase 1 activity is differentially regulated by specific mechanisms during apoptosis, J Biol Chem, 278, 50330, 10.1074/jbc.M302997200 Yim, 2005, Cyclooxygenase-2 inhibits novel ginseng metabolite-mediated apoptosis, Cancer Res, 65, 1952, 10.1158/0008-5472.CAN-04-1740 Zhang, 2006, Ginsenoside Rg1 inhibits tumor necrosis factor-alpha (TNF-alpha)-induced human arterial smooth muscle cells (HASMCs) proliferation, J Cell Biochem, 98, 1471, 10.1002/jcb.20799 Jung, 2009, Down-regulation of AMP-activated protein kinase sensitizes DU145 carcinoma to Fas-induced apoptosis via c-FLIP degradation, Exp Cell Res, 315, 2433, 10.1016/j.yexcr.2009.05.018 Fukushima, 2001, Inhibition by ginseng of colon carcinogenesis in rats, J Korean Med Sci, 16, S75, 10.3346/jkms.2001.16.S.S75 Helms, 2004, Cancer prevention and therapeutics: Panax ginseng, Altern Med Rev, 9, 259 Bae, 2002, Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities, Biol Pharm Bull, 25, 58, 10.1248/bpb.25.58 Park, 2012, Reactive oxygen species mediated ginsenoside Rg3- and Rh2-induced apoptosis in hepatoma cells through mitochondrial signaling pathways, Food Chem Toxicol, 50, 2736, 10.1016/j.fct.2012.05.027 Kim, 2011, Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma in humans, Hepatology, 54, 1661, 10.1002/hep.24539 Wang, 2008, 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action, Br J Cancer, 98, 792, 10.1038/sj.bjc.6604227 Foller, 2009, Regulation of erythrocyte survival by AMP-activated protein kinase, FASEB J, 23, 1072, 10.1096/fj.08-121772 Hawley, 2003, Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade, J Biol, 2, 28 Hong, 2003, Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases, Proc Natl Acad Sci U S A, 100, 8839, 10.1073/pnas.1533136100 Inoki, 2003, TSC2 mediates cellular energy response to control cell growth and survival, Cell, 115, 577, 10.1016/S0092-8674(03)00929-2 Corradetti, 2004, Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz–Jeghers syndrome, Genes Dev, 18, 1533, 10.1101/gad.1199104 Liao, 2006, Enhancement of the release of inflammatory mediators by substance P in rat basophilic leukemia RBL-2H3 cells, J Biomed Sci, 13, 613, 10.1007/s11373-006-9099-1 Jung, 2006, Ginseng saponin metabolite suppresses phorbol ester-induced matrix metalloproteinase-9 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathways in human astroglioma cells, Int J Cancer, 118, 490, 10.1002/ijc.21356 Lemieux, 2003, The AMP-activated protein kinase activator AICAR does not induce GLUT4 translocation to transverse tubules but stimulates glucose uptake and p38 mitogen-activated protein kinases alpha and beta in skeletal muscle, FASEB J, 17, 1658, 10.1096/fj.02-1125com Lee, 2008, Retinoic acid leads to cytoskeletal rearrangement through AMPK-Rac1 and stimulates glucose uptake through AMPK-p38 MAPK in skeletal muscle cells, J Biol Chem, 283, 33969, 10.1074/jbc.M804469200 Berasi, 2006, Inhibition of gluconeogenesis through transcriptional activation of EGR1 and DUSP4 by AMP-activated kinase, J Biol Chem, 281, 27167, 10.1074/jbc.M602416200